Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule. - Wikidata - wikimedia - TriplyDB

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

http://www.wikidata.org/entity/Q39974009

about

Cellular effects of HER3-specific affibody molecules Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules.Phage display and molecular imaging: expanding fields of vision in living subjects.Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification HER2- and EGFR-specific affiprobes: novel recombinant optical probes for cell imaging.Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors.Role of ErbB Receptors in Cancer Cell Migration and Invasion Antibody Therapeutics in Oncology.In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.Engineered proteins pull double duty.Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects.Dual targeting strategies with bispecific antibodies.New advances in molecular recognition based on biomolecular scaffolds.Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds.Detection of a phosphorylated glycine-serine linker in an IgG-based fusion protein.

P2860

Q28727774-6521AAA5-7E5D-454B-8AE6-1376D222AEDC Q33777866-082C2D99-A68D-4906-9A55-98A0CC2882E5 Q33849788-466B0454-3287-41D5-98CA-76EA01E0ECAE Q34722687-8E59EE8A-7636-4EE7-AC2E-03077C037D6A Q34974682-F5844185-6F84-4AB2-8E7F-7A77C9D3DE5F Q35086515-7A4BB7C0-7A3E-459C-94B8-3366B1018054 Q35146230-8DDD0E2B-3918-4521-8596-3C7021CA8429 Q36311027-CC755A03-28F4-4738-9A26-5CFDD6CED4D8 Q36791878-05166F94-7757-43B7-872C-227F5141AFC3 Q37660979-65035838-FEAA-4463-8337-B7C645BC7B47 Q37725479-F5E6229D-7186-4FC4-BA2F-63E7460101D6 Q37730252-5519737E-9421-4DD3-86CC-659B7935C045 Q37972851-25C42A8C-6700-441B-9EEC-C06C3E73A49D Q37997559-76FB87F9-B16A-49E3-B24D-C22D8BD82804 Q38105260-741566CB-5517-402D-9F83-6CAA76E1FE30 Q38929801-203BEC81-BC79-4F54-9DDC-DA50846FC192 Q42330118-6C8516EA-BEE1-48B2-827F-389720CB1941

P2860

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

http://www.wikidata.org/entity/Q39974009

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@en

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@nl

type

label

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@en

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@nl

prefLabel

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@en

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@nl

P1433

Q39974009-51275D7D-0C9E-4A86-AFE0-9DD3A1C9C833

P1476

Q39974009-0B991F89-6508-49B9-AC4D-DDB1683B8CF6

P2093

Q39974009-14D108D9-6F8D-4908-8B02-B8EFB31CF432

Q39974009-15ED4E6C-511A-4BAC-9497-29931FA824CE

Q39974009-4859687B-F197-43AB-A15C-666E3CE05FEB

Q39974009-69A2D1AF-13D0-4F3B-A0D5-89DBE7EFE290

Q39974009-8501E0D0-61F4-466F-932B-2B5ADC011D88

Q39974009-A317B601-4297-473E-B8C8-BA111BC86401

Q39974009-D9F69CC9-067E-4163-8751-EDEFD503D4DB

Q39974009-F189670A-F641-4C2A-972E-6967340AD9F3

P2860

Q39974009-03B2A841-0C0F-4CA9-BBBC-D7627592C54D

Q39974009-137435D5-0D6E-4630-B6F8-EFB6A1059D5D

Q39974009-291C80DE-DD8A-4F7F-853A-101495C0B8BF

Q39974009-298753F3-790B-4BBB-9CF2-608BC1B4D0C3

Q39974009-2E066294-6E66-4564-907F-12B50EACEB4F

Q39974009-31B7CEB2-7879-4232-BEBF-604C33C95CDE

Q39974009-3300D626-B8A1-4FB2-813D-7560F246A30A

Q39974009-3471A36C-5436-479B-98B0-D0B40750D840

Q39974009-3D6C5844-D316-41E2-A3DB-FBFD6D0AB103

Q39974009-41B4B358-CF8F-4631-8E62-9ACF843F9427

P304

Q39974009-B30AD2B2-8AB4-46EB-ADC0-E260C920F348

P31

Q39974009-426D81F5-1E95-4190-BEF8-974BCFD01625

P356

Q39974009-7B9E5450-8116-4945-B01B-137966E71917

P433

Q39974009-E66A5437-E4C0-45D9-B966-BF3DBB4DDE85

P478

Q39974009-04E69921-E5F2-4BBE-9A03-2F848388F95F

P50

Q39974009-3A578CD3-D926-4673-8DD7-7AFB0760A6A2

Q39974009-48922C74-4569-49B9-BEA4-60DF8BAE71B1

P577

Q39974009-BEA640A5-7A52-47A3-96E1-A11D2A5AF5B1

P698

Q39974009-00F249DD-75BF-4630-9AFF-A48763CB48A7

P356

P1433

Biotechnology and Applied Biochemistry

P1476

Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.

@en

P2093

Fredrik Y Frejd

http://www.w3.org/2001/XMLSchema#string

Helene Andersson-Svahn

http://www.w3.org/2001/XMLSchema#string

Jörgen Carlsson

http://www.w3.org/2001/XMLSchema#string

Lars Gedda

http://www.w3.org/2001/XMLSchema#string

Lina Ekerljung

http://www.w3.org/2001/XMLSchema#string

Mikaela Friedman

http://www.w3.org/2001/XMLSchema#string

Sara Lindström

http://www.w3.org/2001/XMLSchema#string

Stefan Ståhl

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantification of human serum proteins without interference by heterophilic serum antibodies.

Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase.

Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A.

Binding proteins from alternative scaffolds.

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.

Isolation of scFvs to in vitro produced extracellular domains of EGFR family members.

Tumor imaging using a picomolar affinity HER2 binding affibody molecule.

Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy.

Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor.

P304

121-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/BA20090096

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Hjalmar Brismar

Helene Andersson-Svahn

P577

2009-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19492986

http://www.w3.org/2001/XMLSchema#string